Long-Acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-Frequency Drug Resistance in Humanized Mice. [electronic resource]
Producer: 20200928ISSN:- 1098-5514
- Animals
- Anti-HIV Agents -- pharmacology
- Disease Models, Animal
- Drug Resistance, Viral -- drug effects
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Mice
- Mutation
- Pre-Exposure Prophylaxis -- methods
- Reverse Transcriptase Inhibitors -- pharmacology
- Rilpivirine -- pharmacology
- Vagina -- virology
- Virus Replication -- drug effects
- gag Gene Products, Human Immunodeficiency Virus -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.